Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARHGEF10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC202025 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
WHSC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACACB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCSK7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APPBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MALAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HDAC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724250 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPRY4-IT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRNAU1AP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTLL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MUM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLR2J2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on